PAVM
PAVM
NASDAQ · Health Care

Pavmed Inc

$5.43
+0.07 (+1.31%)
Financial Highlights (FY 2026)
Revenue
732.6K
Net Income
4.14M
Gross Margin
-207.0%
Profit Margin
564.8%
Rev Growth
-42.8%
D/E Ratio
0.33
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin -207.0% -207.0% 44.0% 44.0%
Operating Margin -30,794.4% -27,714.9% 8.6% 7.3%
Profit Margin 564.8% 536.6% 6.6% 6.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 732.6K 1.28M 6.38M 6.70M
Gross Profit -1,516,816 -2,653,167 2.81M 2.95M
Operating Income -225,605,713 -355,160,296 548.6K 488.5K
Net Income 4.14M 6.51M 418.8K 465.2K
Gross Margin -207.0% -207.0% 44.0% 44.0%
Operating Margin -30,794.4% -27,714.9% 8.6% 7.3%
Profit Margin 564.8% 536.6% 6.6% 6.9%
Rev Growth -42.8% -42.8% +12.0% -1.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 4.30M 4.30M 2.13M 1.84M
Total Equity 13.17M 13.17M 6.09M 6.42M
D/E Ratio 0.33 0.33 0.35 0.29
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -224,513,810 -373,076,997 672.1K 715.5K
Free Cash Flow 349.1K 300.8K